Skip to main content
Knowledge4Policy
Knowledge for policy

Supporting policy with scientific evidence

We mobilise people and resources to create, curate, make sense of and use knowledge to inform policymaking across Europe.

  • Dataset | 01 Oct 2016

OECD - Revealed technological advantage in biotechnologies

Data on the revealed technological advantage in biotechnologies in 2000-03 and 2010-13.

Index based on IP5 patent families.

The revealed technological advantage index is calculated as the share of country (or economy) in biotechnology patents relative to the share of country (or economy) in total patents. Only countries and economies with more than 100 patents per period are included in the figure.

Biotechnology firms use biotechnology to produce goods or services and/or to perform biotechnology R&D. These firms are captured by biotechnology firm surveys.

Dedicated biotechnology firms devote at least 75% of their production of goods and services, or R&D, to biotechnology.

This dataset is part of the OECD Key Biotech Indicators.